These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7496597

  • 21. A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas.
    Søland TM, Husvik C, Koppang HS, Boysen M, Sandvik L, Clausen OP, Christoffersen T, Bryne M.
    J Oral Pathol Med; 2008 Oct; 37(9):535-42. PubMed ID: 18284542
    [Abstract] [Full Text] [Related]

  • 22. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
    Nishimura Y, Nagata Y, Okajima K, Mitsumori M, Hiraoka M, Masunaga S, Ono K, Shoji K, Kojima H.
    Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
    [Abstract] [Full Text] [Related]

  • 23. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE, Schrijvers ML, Slagter-Menkema L, Mastik M, Langendijk JA, de Bock GH, Roodenburg JL, van der Laan BFAM, van der Wal JE, Schuuring E.
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [Abstract] [Full Text] [Related]

  • 24. [Expression and clinical significance of CD1a+ dendritic cells in glottic squamous cell carcinoma].
    Chen WK, Chen FJ, Zeng ZY, Wu GH, Guo ZM, Wei MW, Yang AK, Zhang Q, He JH, Hou JH.
    Ai Zheng; 2005 Sep; 24(9):1124-6. PubMed ID: 16159438
    [Abstract] [Full Text] [Related]

  • 25. Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomas.
    Piffkò J, Bànkfalvi A, Ofner D, Bryne M, Rasch D, Joos U, Böcker W, Schmid KW.
    Br J Cancer; 1997 Sep; 75(10):1543-6. PubMed ID: 9166951
    [Abstract] [Full Text] [Related]

  • 26. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N, Mori T, Yoshimoto S, Ito Y, Kobayashi K, Ken H, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Itami J.
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [Abstract] [Full Text] [Related]

  • 27. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K, Aoki Y, Karasawa K, Hasezawa K, Muta N, Nakagawa K, Terahara A, Onogi Y, Sasaki Y, Akanuma A.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1059-64. PubMed ID: 7961012
    [Abstract] [Full Text] [Related]

  • 28. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer.
    Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA, Reddy SP.
    Int J Radiat Oncol Biol Phys; 2000 Jan 01; 46(1):21-6. PubMed ID: 10656367
    [Abstract] [Full Text] [Related]

  • 29. Prognostic significance of EGF receptor expression in early glottic cancer.
    Demiral AN, Sarioglu S, Birlik B, Sen M, Kinay M.
    Auris Nasus Larynx; 2004 Dec 01; 31(4):417-24. PubMed ID: 15571917
    [Abstract] [Full Text] [Related]

  • 30. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.
    Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, Waldron J, Cummings BJ.
    Int J Radiat Oncol Biol Phys; 1998 May 01; 41(2):347-53. PubMed ID: 9607350
    [Abstract] [Full Text] [Related]

  • 31. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M.
    Strahlenther Onkol; 2004 Feb 01; 180(2):84-90. PubMed ID: 14762660
    [Abstract] [Full Text] [Related]

  • 32. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
    Jones DA, Mendenhall CM, Kirwan J, Morris CG, Donnan A, Holwerda S, Kraus ST, Mann CJ, Grant JR, Donnan B, Mendenhall WM.
    Am J Clin Oncol; 2010 Dec 01; 33(6):587-90. PubMed ID: 20051812
    [Abstract] [Full Text] [Related]

  • 33. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ, Regine WF, Mohiuddin M, Zollinger W, Machtay M, Lee J, Schultz D, Rudoltz MS.
    Radiat Oncol Investig; 1999 Dec 01; 7(1):42-8. PubMed ID: 10030623
    [Abstract] [Full Text] [Related]

  • 34. Quantitation of nucleolar organizer regions by image analysis in glottic squamous cell carcinoma.
    Barnes P, Sagar S, Laybolt K, Roy P, Foyle A.
    Clin Invest Med; 1999 Apr 01; 22(2):36-43. PubMed ID: 10340102
    [Abstract] [Full Text] [Related]

  • 35. Cancer of the larynx--treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients.
    Jørgensen K, Godballe C, Hansen O, Bastholt L.
    Acta Oncol; 2002 Apr 01; 41(1):69-76. PubMed ID: 11990522
    [Abstract] [Full Text] [Related]

  • 36. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.
    Korkmaz H, Du W, Yoo GH, Enamorado II, Lin HS, Adsay V, Kewson D, Ensley JF, Shibuya TY, Jacobs JR, Kim H.
    Am J Otolaryngol; 2005 Apr 01; 26(2):77-82. PubMed ID: 15742257
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer.
    Reddy SP, Mohideen N, Marra S, Marks JE.
    Radiother Oncol; 1998 May 01; 47(2):161-6. PubMed ID: 9683364
    [Abstract] [Full Text] [Related]

  • 39. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
    Matsumoto F, Ohba S, Fujimaki M, Ikeda K.
    Auris Nasus Larynx; 2016 Aug 01; 43(4):440-5. PubMed ID: 26739949
    [Abstract] [Full Text] [Related]

  • 40. Carcinoma of the larynx. Growth, p-classification and grading of squamous cell carcinoma of the vocal cords.
    Glanz HK.
    Adv Otorhinolaryngol; 1984 Aug 01; 32():1-123. PubMed ID: 6369947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.